Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Denali Therapeutics Inc
(NQ:
DNLI
)
21.78
-0.09 (-0.41%)
Streaming Delayed Price
Updated: 12:23 PM EDT, Aug 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Denali Therapeutics Inc
< Previous
1
2
3
Next >
Denali Therapeutics Reveals New Interim Data From Early-Stage Hunter Syndrome Study
February 23, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via
Benzinga
Expert Ratings for Denali Therapeutics
January 30, 2023
Via
Benzinga
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
November 02, 2022
The biopharmaceutical stock was actually up as much as 12.4% before falling a bit at the close.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 18, 2022
Gainers
Via
Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...
Via
Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
June 23, 2022
Upgrades
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.
Via
InvestorPlace
AbbVie Stock Breaks Its Stride As Key Executive Departs For Flagship
April 13, 2022
Flagship Pioneering is swiping one of AbbVie's biggest names.
Via
Investor's Business Daily
7 F-Rated Stocks to Avoid During the Downturn
March 23, 2022
It's easy to find hard hit stocks in this market, but what's harder to determine is which stocks are truly F-rated stocks among the losers.
Via
InvestorPlace
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
February 14, 2022
As previously announced, Denali Therapeutics Inc (NASDAQ: DNLI) was informed via e-mail communication from the FDA that DNL919 (ATV:TREM2) Investigational New Drug (IND...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
48 Biggest Movers From Yesterday
January 14, 2022
Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 13, 2022
Gainers Rockwell Medical (NASDAQ:RMTI) st...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Dips 250 Points; Taiwan Semiconductor Shares Gain
January 13, 2022
Toward the end of trading Thursday, the Dow traded up 0.03% to 36,301.73 while the NASDAQ fell 1.67% to 14,934.36. The S&P also fell, dropping, 0.77% to 4,689.96. The U.S. has...
Via
Benzinga
Denali Stock Tumbles; Why Biogen Isn't The Only Alzheimer's Play Under Pressure
January 13, 2022
Denali Therapeutics is under pressure after the FDA put its study on hold.
Via
Investor's Business Daily
26 Stocks Moving In Thursday's Mid-Day Session
January 13, 2022
Gainers Dave Inc. (NASDAQ: DAVE) gained 29.4% to $6.73. Takung Art Co., Ltd. (NASDAQ: TKAT) shares gained 18.6% to $4.1499. Traders are circulating earlier news that China is...
Via
Benzinga
Mid-Morning Market Update: Markets Rise; Delta Air Lines Profit Tops Estimates
January 13, 2022
Following the market opening Thursday, the Dow traded up 0.37% to 36,423.44 while the NASDAQ rose 0.12% to 15,206.73. The S&P also rose, gaining, 0.21% to 4,736.11. The U.S....
Via
Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
The FDA has issued a clinical hold on Denali Therapeutics Inc's (NASDAQ: DNLI) Investigational New Drug (IND) application for DNL919 (ATV:TREM2). TREM2 is...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...
Via
Benzinga
Jim Cramer Says This Stock Is 'Really Cheap'
December 16, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Academy Sports and Outdoors (NYSE:
Via
Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
October 07, 2021
Denali Therapeutics Inc (NASDAQ: DNLI) announced data from the Phase 1 trial evaluating DNL343, eIF2B activator, in 95 healthy volunteers. DNL343 was generally...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.